| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5690688 | Gynecologic Oncology | 2016 | 5 Pages |
Abstract
Our study showed an association between perioperative β blocker use and longer overall survival in patients undergoing primary ovarian cancer cytoreductive surgery. A prospective randomized clinical trial in this population would further validate these results.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Ahmed MD, Elizabeth L. MD, Cassandra MD, Jennifer MD, Cassandra MD, Ryan MD, Mian M.K MD, PhD, Shitanshu MD, Sandeep MS, Laurel MD, Amy Mc MD,